PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.06%
Revenue growth above 1.5x ACB.TO's 4.72%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
127.38%
Gross profit growth 1.25-1.5x ACB.TO's 104.82%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
38.32%
EBIT growth above 1.5x ACB.TO's 18.05%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
38.32%
Operating income growth under 50% of ACB.TO's 117.90%. Michael Burry would be concerned about deeper cost or sales issues.
65.75%
Positive net income growth while ACB.TO is negative. John Neff might see a big relative performance advantage.
66.67%
EPS growth 1.25-1.5x ACB.TO's 49.67%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
66.67%
Diluted EPS growth 1.25-1.5x ACB.TO's 49.67%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
5.20%
Share count expansion well above ACB.TO's 8.86%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.20%
Diluted share count expanding well above ACB.TO's 9.06%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
293.60%
Positive OCF growth while ACB.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
184.22%
Positive FCF growth while ACB.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
-34.22%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-9.09%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
2504.48%
Positive long-term OCF/share growth while ACB.TO is negative. John Neff would see a structural advantage in sustained cash generation.
162.10%
5Y OCF/share CAGR above 1.5x ACB.TO's 93.74%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
185.89%
3Y OCF/share CAGR above 1.5x ACB.TO's 86.18%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-113.65%
Negative 10Y net income/share CAGR while ACB.TO is at 51.52%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-168.21%
Negative 5Y net income/share CAGR while ACB.TO is 98.22%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-153.14%
Negative 3Y CAGR while ACB.TO is 95.93%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
9548.01%
10Y equity/share CAGR above 1.5x ACB.TO's 151.85%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-27.53%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-56.57%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.57%
AR growth well above ACB.TO's 4.83%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.26%
Inventory shrinking or stable vs. ACB.TO's 29.47%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.91%
Asset growth 1.25-1.5x ACB.TO's 2.63%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
-2.10%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-19.58%
We’re deleveraging while ACB.TO stands at 1.40%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
271.70%
We increase R&D while ACB.TO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
36.61%
SG&A growth well above ACB.TO's 16.92%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.